Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitin-specific protease 7 exacerbates acute pancreatitis progression by enhancing ATF4-mediated autophagy. | In Vitro Cell Dev Biol Anim | 2025 | 39875698 | PubTator, text mining | PubMed |
| Targeting ARPC1B Overcomes Immune Checkpoint Inhibitor Resistance in Glioblastoma by Reversing Protumorigenic Macrophage Polarization. | Cancer Res | 2025 | 39841088 | PubTator, text mining | PubMed |
| A novel approach for target deconvolution from phenotype-based screening using knowledge graph. | Sci Rep | 2025 | 39827292 | PubTator, text mining | PubMed |
| USP7 Inhibitors Destabilize EBNA1 and Suppress Epstein-Barr Virus Tumorigenesis. | J Med Virol | 2025 | 39821265 | PubTator, text mining | PubMed |
| Targeting deubiquitinase USP7-mediated stabilization of XPO1 contributes to the anti-myeloma effects of selinexor. | J Transl Med | 2025 | 39806439 | PubTator, text mining | PubMed |
| Cabozantinib selectively induces proteasomal degradation of p53 somatic mutant Y220C and impedes tumor growth. | J Biol Chem | 2025 | 39793887 | PubTator, text mining | PubMed |
| Effect of the Deubiquitinating Peptidase 7 (USP7) on Hepatitis B Virus (HBV) Replication and the Antiviral Efficacy of Entecavir (ETV). | Mol Biotechnol | 2025 | 39715932 | PubTator, text mining | PubMed |
| Involvement of USP7 in aggravating Kawasaki disease by promoting TGFβ2 signaling mediated endothelial-mesenchymal transition and coronary artery remodeling. | Int Immunopharmacol | 2025 | 39674001 | PubTator, text mining | PubMed |
| O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner. | Neuro Oncol | 2025 | 39671515 | PubTator, text mining | PubMed |
| USP7 Inhibition Promotes Early Osseointegration in Senile Osteoporotic Mice. | J Dent Res | 2025 | 39651622 | PubTator, text mining | PubMed |
| Retraction Note: Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39531046 | PubTator, text mining | PubMed |
| Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer. | J Adv Res | 2025 | 39505147 | PubTator, text mining | PubMed |
| USP7 facilitates deubiquitination of LRRC42 in colorectal cancer to accelerate tumorigenesis and augment Wnt/β-catenin signaling. | Biochim Biophys Acta Mol Cell Res | 2025 | 39393471 | PubTator, text mining | PubMed |
| Stereo-selectivity of enantiomeric inhibitors to ubiquitin-specific protease 7 (USP7) dissected by molecular docking, molecular dynamics simulations, and binding free energy calculations. | Mol Divers | 2025 | 39298085 | PubTator, text mining | PubMed |
| NAD+ Metabolism Reprogramming Mediates Irradiation-Induced Immunosuppressive Polarization of Macrophages. | Int J Radiat Oncol Biol Phys | 2025 | 39127084 | PubTator, text mining | PubMed |
| Virtual screening of natural products targeting ubiquitin-specific protease 7. | J Biomol Struct Dyn | 2025 | 38361286 | PubTator, text mining | PubMed |
| Predicting the impact of rare variants on RNA splicing in CAGI6. | Hum Genet | 2025 | 38170232 | PubTator, text mining | PubMed |
| The Role and Mechanism of Deubiquitinase USP7 in Tumor-Associated Inflammation. | Biomedicines | 2024 | 39767641 | PubTator, text mining | PubMed |
| A genome-wide association study of anti-Müllerian hormone (AMH) levels in Samoan women. | medRxiv | 2024 | 39677481 | PubTator, text mining | PubMed |
| Pseudogene KRT17P3 Promotes NSCLC Progression Through Mir-338-3p/USP7/C-Myc. | Anticancer Res | 2024 | 39626929 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=15